Erik J. Dasbach

5.5k total citations · 1 hit paper
66 papers, 4.4k citations indexed

About

Erik J. Dasbach is a scholar working on Epidemiology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Erik J. Dasbach has authored 66 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 17 papers in Surgery and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Erik J. Dasbach's work include Cervical Cancer and HPV Research (24 papers), Hepatitis B Virus Studies (21 papers) and Genital Health and Disease (12 papers). Erik J. Dasbach is often cited by papers focused on Cervical Cancer and HPV Research (24 papers), Hepatitis B Virus Studies (21 papers) and Genital Health and Disease (12 papers). Erik J. Dasbach collaborates with scholars based in United States, Sweden and Norway. Erik J. Dasbach's co-authors include Elamin H. Elbasha, Ralph P. Insinga, Dennis G. Fryback, Ronald Klein, Glenn Davies, Steven M. Teutsch, Evan R. Myers, William H. Herman, Richard C. Eastman and Kai‐Li Liaw and has published in prestigious journals such as Gastroenterology, PLoS ONE and Diabetes Care.

In The Last Decade

Erik J. Dasbach

65 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Beaver Dam Health Outcomes study

1993 664 citations Dennis G. Fryback, Erik J. Dasbach et al. Medical Decision Making profile →

Peers

Countries citing papers authored by Erik J. Dasbach

Since Specialization

Citations

This map shows the geographic impact of Erik J. Dasbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik J. Dasbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik J. Dasbach more than expected).

Fields of papers citing papers by Erik J. Dasbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik J. Dasbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik J. Dasbach. The network helps show where Erik J. Dasbach may publish in the future.

Co-authorship network of co-authors of Erik J. Dasbach

This figure shows the co-authorship network connecting the top 25 collaborators of Erik J. Dasbach. A scholar is included among the top collaborators of Erik J. Dasbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik J. Dasbach. Erik J. Dasbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Planning for monitoring the introduction and effectiveness of new vaccines using real-word data and geospatial visualization: An example using rotavirus vaccines with potential application to SARS-CoV-2 2021 ·Vaccine X ·T. Christopher Mast, (unknown), Erik J. Dasbach, Craig S. Roberts, Michelle G. Goveia, Lyn Finelli	6
2	Cost-Effectiveness Of Pneumococcal Vaccines For Adults In The United States 2013 ·Value in Health ·(unknown), (unknown), Megan A. O’Brien, John D. Grabenstein, Erik J. Dasbach	1
3	The Cost-Effectiveness Analysis of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) for Females in Japan 2013 ·Value in Health Regional Issues ·(unknown), Puneet K. Singhal, Machiko Abe, Erik J. Dasbach, Elamin H. Elbasha	8
4	Comparing vaccine effectiveness estimates in cost-effectiveness analyses of pneumococcal vaccination in adults 2013 ·Value in Health ·(unknown), Josephine Mauskopf, Erik J. Dasbach	1
5	Public Health Impact and Cost Effectiveness of Pneumococcal Vaccination for Adults in Puerto Rico 2013 ·Value in Health ·(unknown), Megan A. O’Brien, (unknown), John D. Grabenstein, Erik J. Dasbach	1
6	PCN141 Projecting the Potential Public Health Impact of a 9-Valent HPV Vaccine in the United States 2012 ·Value in Health ·Matthew Pillsbury, K. Kawai, Chijioke Nwankwo, Tracey Weiss, Erik J. Dasbach, Elamin H. Elbasha	1
7	Impact of vaccinating boys and men against HPV in the United States 2010 ·Vaccine ·Elamin H. Elbasha, Erik J. Dasbach	192
8	Cost-effectiveness of the use 23-valent pneumococcal polysaccharide vaccine to prevent secondary bacterial infections related to pandemic influenza in Brazil 2010 ·International Journal of Infectious Diseases ·Megan A. O’Brien, Praveen Dhankhar, John D. Grabenstein, Erik J. Dasbach	1
9	Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model 2009 ·BMC Infectious Diseases ·Ralph P. Insinga, Erik J. Dasbach, Elamin H. Elbasha	126
10	Awareness of human papillomavirus in a cohort of nearly 70,000 women from four Nordic countries 2008 ·Acta Obstetricia Et Gynecologica Scandinavica ·Bugge Nøhr, Christian Munk, Laufey Tryggvadóttír, Pär Sparén, Trung N. Tran, Mari Nygård, Gry Baadstrand Skare, Erik J. Dasbach, (unknown), Susanne K. Kjær	23
11	The Burden of Genital Warts: A Study of Nearly 70,000 Women from the General Female Population in the 4 Nordic Countries 2007 ·The Journal of Infectious Diseases ·Susanne K. Kjær, Trung N. Tran, Pär Sparén, Laufey Tryggvadóttír, Christian Munk, Erik J. Dasbach, Kai‐Li Liaw, Jan F. Nygård, Mari Nygård	183
12	The Burden of Appendicitis-Related Hospitalizations in the United States in 1997 2004 ·Surgical Infections ·Glenn Davies, Erik J. Dasbach, Steven M. Teutsch	60
13	The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma 2004 ·Clinical Therapeutics ·Glenn Davies, Erik J. Dasbach, Nancy C. Santanello, Barbara Knorr, Donna L. Bratton	14
14	Cost Effectiveness of ACE Inhibitor Treatment for Patients with Type 1 Diabetes Mellitus 2004 ·PharmacoEconomics ·(unknown), Stephen W. Sorensen, Diane L. Manninen, Theodore J. Thompson, (unknown), Carlyn E. Orians, Edward W. Gregg, Richard C. Eastman, Erik J. Dasbach, William H. Herman, Jeffrey M. Newman, Andrew S. Narva, David Ballard, Michael M. Engelgau	14
15	Mortality and Costs of Acute Renal Failure Associated with Amphotericin B Therapy 2001 ·Clinical Infectious Diseases ·David W. Bates, L. Joseph Su, Donghui Yu, Glenn M. Chertow, Diane L. Seger, Daniel Gomes, Erik J. Dasbach, Richard Platt	330
16	The Multinational Impact of Migraine Symptoms on Healthcare Utilisation and Work Loss 2001 ·PharmacoEconomics ·William C. Gerth, George W. Carides, Erik J. Dasbach, W. Hester Visser, Nancy C. Santanello	77
17	Burden of Aspergillosis‐Related Hospitalizations in the United States 2000 ·Clinical Infectious Diseases ·Erik J. Dasbach, Glenn Davies, Steven M. Teutsch	125
18	Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: The losartan heart failure ELITE quality of life substudy 2000 ·Quality of Life Research ·Alan Cowley, Brian L. Wiens, Robert Segal, Michael W. Rich, Nancy C. Santanello, Erik J. Dasbach, Bertram Pitt	26
19	The Cost-Effectiveness of Losartan versus Captopril in Patients with Symptomatic Heart Failure 1999 ·Cardiology ·Erik J. Dasbach, Michael W. Rich, Robert Segal, William C. Gerth, George W. Carides, J.R. Cook, James F. Murray, Duane Snavely, Bertram Pitt	17
20	The Beaver Dam Health Outcomes study breakdown → 1993 ·Medical Decision Making ·Dennis G. Fryback, Erik J. Dasbach, Ronald Klein, (unknown), (unknown), (unknown)	664

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact